Skip to main content

ORIGINAL RESEARCH article

Front. Mol. Biosci.
Sec. Molecular Diagnostics and Therapeutics
Volume 11 - 2024 | doi: 10.3389/fmolb.2024.1440276

Transcriptome-based identification of key actin binding proteins associated with high metastatic potential in breast cancer

Provisionally accepted
Christian Müller Christian Müller Leticia Oliveira-Ferrer Leticia Oliveira-Ferrer Volkmar Mueller Volkmar Mueller Barbara Schmalfeldt Barbara Schmalfeldt Sabine Windhorst Sabine Windhorst *
  • University Medical Center Hamburg-Eppendorf, Hamburg, Germany

The final, formatted version of the article will be published soon.

    Actin binding proteins (ABPs) are essential for the regulation of morphological plasticity required for tumor cells to metastasize. Aim of this study was to perform an unbiased bioinformatic approach to identify the key ABPs significantly associated with the metastatic potential of breast cancer cells.Methods: Microarray data from 181 primary breast cancer samples from our hospital were employed, and all genes belonging to the Gene Ontology term actin cytoskeleton organization obtained from QuickGO. Association with metastasis-free survival probability was tested using Cox proportional hazards regression, and pairwise coexpression by Pearson correlations. Differential expression between different subgroups was analyzed by Wilcoxon tests for dichotomous traits, and Kruskal-Wallis tests for categorical traits. Validation was performed in four publicly available breast cancer datasets.Results: ARHGAP25 was significantly associated with a low, and CFL1, TMSB15A and ACTL8 with a high metastatic potential. A significantly higher expression of CFL1, TMSB15A and ACTL8 mRNA was found in the more aggressive Her2 positive and triple negative subtypes as well as in ER-negative samples. Also, these genes were co-expressed in the same tumors. However, only mRNA levels of CFL1 were increased in pN1 compared to pN0 patients. External validation revealed that CFL1 and TMSB15A had significant associations with consistent hazard ratios in two breast cancer cohorts, and among these CFL1 exhibited the highest Hazard ratios.showed the strongest correlation with the metastatic potential of breast tumors. Thus, targeted inhibition of CFL1 might be a promising approach to treat malignant breast cancer cells.

    Keywords: Actin, metastasis, actin binding proteins, bioinformatics, breast cancer

    Received: 30 May 2024; Accepted: 05 Aug 2024.

    Copyright: © 2024 Müller, Oliveira-Ferrer, Mueller, Schmalfeldt and Windhorst. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Sabine Windhorst, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.